Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826098 · ClinicalTrials.gov registry record · Phase 4
Platelet Rich Plasma (PRP) in Total Knee Replacement
A Phase 4 study, sponsored by Exactech.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00826098 is a Phase 4 study that has completed, run by Exactech. The registered enrollment target is 70 participants.
The verdict
NCT00826098, a Phase 4 study, has completed, sponsored by Exactech.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).
Interventions
- BIOLOGICAL Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826098
The ClinicalTrials.gov registry entry for NCT00826098 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exactech, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Plasma is the first listed.
NCT00826098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00826098 about?
NCT00826098 is a clinical study titled "Platelet Rich Plasma (PRP) in Total Knee Replacement". Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).
What is the current status of trial NCT00826098?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2008-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00826098?
The interventions under investigation include: Platelet Rich Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT00826098?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.